Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akcea, Apellis, Atriva, Calcimedica, Enlivex, Genentech, Genmab, I-Mab, Ionis, Iovance, Neurotrope, Oncopeptides, Partner Therapeutics, Windmil, Zai.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altapure, Biodesix, Biotronik, Clinical Genomics, Procept Biorobotics, Roche.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Adamis, Aileron, Alucent, Auris, Biolinerx, Compugen, Cytovation, Genentech, GT, Ironwood, Macrogenics, Mersana, Mina, Nascent, Novartis, NS Pharma, Radius, Transcenta, Vir, Zynerba.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Antisense, Arch Biopartners, Covis, Daiichi Sankyo, Diffusion, Incyte, Mezzion.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Freenome, Lucence, Oncolytics Biotech, Orteq Sports Medicine.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acadia, Aeglea, Alnylam, Arena, Argenx, Atara, Clene, Dermavant, Durect, Glenmark, GSK, Immunocore, Innovent, Janssen, Lilly, Mesoblast, Novavax, Oncolytics, Regeneron, Sanofi, Synairgen, Teva.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boehringer, Daiichi, Geron, Incuron, Incyte, Leo, Navidea, Nektar, Oncopeptides, Retinset, Roche, Samumed, Syndax, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Delft, Shuwen, Thirona.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antisense, Apollomics, Arvelle, Entera Bio, Galapagos, Gilead, Kadmon, Poseida, Tonix.